• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Summit Therapeutics Inc. - Common Stock (NQ:SMMT)

    18.66 -0.57 (-2.96%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 29, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Summit Therapeutics Inc. - Common Stock

    < Previous 1 2
    ...
    10 11 12 13 14 15 16 17 Next >
    Earnings Scheduled For February 20, 2024
    Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. 
    Via Benzinga
    Summit Therapeutics to Host Fourth Quarter & Full Year 2023 Financial Results & Operational Progress Call on February 20, 2024
    From Summit Therapeutics Inc.
    Via Business Wire
    Summit Therapeutics to Present at Oppenheimer’s 34th Annual Healthcare Life Sciences Conference
    From Summit Therapeutics Inc.
    Via Business Wire
    Chart Of The Day: Summit Therapeutics Begins To Soar
    Summit Therapeutics Inc., a biopharmaceutical company, researches and develops primarily oncology therapies in the United States and the United Kingdom. 
    Via Talk Markets
    Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares... 
    Via Benzinga
    Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market... 
    Via Benzinga
    Topics Stocks
    Summit Therapeutics Announces Updated Phase II Data for Ivonescimab at 42nd Annual J.P. Morgan Healthcare Conference
    From Summit Therapeutics Inc.
    Via Business Wire
    Summit Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Summit Therapeutics Inc.
    Via Business Wire
    Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023
    From Summit Therapeutics Inc.
    Via Business Wire
    Laura Chow, MD, Cancer Immunotherapy Trailblazer, Joins Summit as Senior Vice President of Clinical Development
    From Summit Therapeutics Inc.
    Via Business Wire
    Ivonescimab’s Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023
    From Summit Therapeutics Inc.
    Via Business Wire
    Earnings Scheduled For November 7, 2023
    Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
    Via Benzinga
    Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday
    U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)
    Via AB Newswire
    Topics Death
    Summit Therapeutics to Host Q3 2023 Financial Results & Operational Progress Call on November 7, 2023
    From Summit Therapeutics Inc.
    Via Business Wire
    H. Jack West, MD, Renowned Oncologist & Lung Cancer Expert, Joins Summit Therapeutics as Vice President of Clinical Development
    From Summit Therapeutics Inc.
    Via Business Wire
    Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc. 
    Via Benzinga
    Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
    U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Summit Therapeutics Appoints Proven Biotech Leader Manmeet S. Soni as Chief Operating Officer
    From Summit Therapeutics Inc.
    Via Business Wire
    5 Meme Stocks to Sell Immediately, According to AI
    As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal
    Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for a novel anti-inflammatory to One Bio of Florida in a $1 billion deal. One Bio will make an $21.5 million payment upfront along with a... 
    Via Talk Markets
    12 Health Care Stocks Moving In Monday's Intraday Session
     
    Via Benzinga
    Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration... 
    Via Benzinga
    Cleveland-Cliffs, United States Steel, monday.com And Other Big Stocks Moving Higher On Monday
    U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Monday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2023
    From Summit Therapeutics Inc.
    Via Business Wire
    Summit Therapeutics to Host Q2 2023 Financial Results & Operational Progress Call on August 9, 2023
    From Summit Therapeutics Inc.
    Via Business Wire
    AlloVir, DigitalOcean And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. AlloVir, Inc. (NASDAQ: ALVR) shares dipped 24.1% to $3.74 in pre-market... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
     
    Via Benzinga
    Promising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023
    From Summit Therapeutics Inc.
    Via Business Wire
    Ivonescimab Updated Data to be Featured at ASCO 2023
    From Summit Therapeutics Inc.
    Via Business Wire
    < Previous 1 2
    ...
    10 11 12 13 14 15 16 17 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.